ArticlePlant biotechnology journal2024

Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.

Shiva Izadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.